Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
57.00
+2.51 (4.61%)
At close: Sep 16, 2025, 4:00 PM EDT
57.00
0.00 (0.00%)
After-hours: Sep 16, 2025, 4:10 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $351.69 million as of September 16, 2025. Its market cap has increased by 4,320.40% in one year.
Market Cap
351.69M
Enterprise Value
300.83M
1-Year Change
4,320.40%
Ranking
Category
Stock Price
$57.00
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $351.69M, an increase of 27.35%. That is a compound annual growth rate of 4.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 336.20M | 150.59% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | 70.09M | -59.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |